Citroflavonoids as Promising Agents for Drug Discovery in Diabetes and Hypertension: A Systematic Review of Experimental Studies
Flavonoids are naturally occurring compounds widely distributed in the <i>Citrus</i> genus. These natural compounds have many health benefits, mainly for metabolic and cardiovascular diseases. In fact, some these compounds are components of drug products with approved indications for per...
Main Authors: | Rolffy Ortiz-Andrade, Jesús Alfredo Araujo León, Juan Carlos Sánchez-Salgado, Amanda Sánchez-Recillas, Priscila Vazquez-Garcia, Emanuel Hernández-Núñez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/22/7933 |
Similar Items
-
A Pharmacokinetic Study of Mix-160 by LC-MS/MS: Oral Bioavailability of a Dosage Form of Citroflavonoids Mixture
by: Jesús Alfredo Araujo-León, et al.
Published: (2022-01-01) -
Preclinical Safety Profile of an Oral Naringenin/Hesperidin Dosage Form by In Vivo Toxicological Tests
by: Carla Georgina Cicero-Sarmiento, et al.
Published: (2022-05-01) -
Hypoglycemic and Antihyperglycemic Potential of Flavonoid Fraction from <i>Citrus sinensis</i> (L.) Osbeck in Normoglycemic and Diabetic Rats
by: Jesús Alfredo Araujo-León, et al.
Published: (2023-09-01) -
Review on anticancer activity of flavonoid derivatives: Recent developments and future perspectives
by: Mani Rajasekar, et al.
Published: (2023-12-01) -
Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer
by: Maria Beatriz Madureira, et al.
Published: (2023-02-01)